ANIP - ANI Pharmaceuticals beats by $0.25 beats on revenue May, 09 2019 08:31 AM ANI Pharmaceuticals Inc. ANI Pharmaceuticals (NASDAQ:ANIP): Q1 Non-GAAP EPS of $1.30 beats by $0.25; GAAP EPS of $0.04 misses by $0.24.More news on: ANI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...